FeesSafety
Pluang+

BitMine's Ether holdings valued $5.3B below purchase cost at fiscal year-end, showing a 26.6% paper loss.

Protocol Fundamentals
11 Nov 2026, 23:19 WIB
Tokenpost
View Source
Bearish
BitMine's Ether holdings valued $5.3B below purchase cost at fiscal year-end, showing a 26.6% paper loss.

At the end of its fiscal year, BitMine's Ether (ETH) holdings were valued at $14.6 billion, which is $5.3 billion less than their original purchase cost of $19.9 billion. This represents a 26.6% valuation gap, meaning the current value is about 73.4% of what was paid. This gap reflects a paper shortfall but does not necessarily mean BitMine sold any ETH or realized a loss. The figures highlight the difference between the asset's acquisition cost and its year-end market value, important for understanding the company's crypto treasury position at the reporting cutoff.

BitMine's Ether holdings valuation gap is the story's focus, provided here with Pluang's cryptocurrency market data as context. For readers following major cryptocurrencies on Pluang, as of Nov 12, 2026 04:22 WIB, 31 of 50 major cryptocurrencies rose while 18 fell. Notable price movements include UNI at Rp118.363 with a 1-day change of -2.62% and a Pluang order activity of 75% Sell / 25% Buy, DOT at Rp15.458 with +2.53% and 23% Sell / 77% Buy, and CRV at Rp4.426 with -2.23% and 0% Sell / 100% Buy.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
3 hours ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
3 hours ago
Okeanis Eco Tankers declares $7 dividend per share, payable December 1, 2026.

Okeanis Eco Tankers declares $7 dividend per share, payable December 1, 2026.

Okeanis Eco Tankers Corp announced a dividend of $7.00 per common share, approved on November 11, 2026. The dividend will be paid on December 1, 2026, with shares on the Oslo Stock Exchange and New York Stock Exchange having different ex-dividend dat...

Company Fundamentals
Neutral
5 hours ago
Bitway surges 16.12% leading crypto gains as most major coins fall

Bitway surges 16.12% leading crypto gains as most major coins fall

Bitway (BTW) led gains among 90 large cryptocurrencies, rising 16.12% to $1.15, despite a broader market downturn where 62 of 90 assets fell. Other notable gainers included Gram (10.11%), Pi Network (8.51%), Lighter (7.32%), and Internet Computer (5....

Bearish
5 hours ago
Bitcoin's Bull Score hits zero, signaling extreme bearishness amid price drop to $73K.

Bitcoin's Bull Score hits zero, signaling extreme bearishness amid price drop to $73K.

Bitcoin's Bull Score Index has fallen to zero, indicating the most bearish market conditions based on 10 key indicators. This drop coincides with Bitcoin's price retreat toward $73,000 and reflects weakening investor confidence due to ETF withdrawals...

Technical Signals
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App